AzTrials
AzTrials

Smoking CessationPERSPECTNCT02200432

Patient Experience Recommender System for Persuasive Communication Tailoring

A study testing PERSPeCT Recommender System in people with Smoking Cessation, run by University of Massachusetts, Worcester at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to maximize patient perspective and effectively support lifestyle choices, investigators will develop the "Patient Experience Recommender System for Persuasive Communication Tailoring." PERSPeCT is a computer system that will assess adult smokers' perspective, to understand the patient's… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Smoking Cessation
What is being tested?
PERSPeCT Recommender System
Could I receive a placebo?
No, everyone receives an active treatment
How many people
972 participants
Where
1 siteUnited States
Study dates
May 2014to Jun 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult smokers, 18 years of age or older with Internet access
  • Pregnant women.
  • English speakers able to obtain consent

Who cannot join

  • Adult unable to consent
  • Infants, Children, Teenagers (those under the age of 18 years old)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The University of Massachusetts Medical School

    Worcester, Massachusetts, 01655

Other trials in United States

About this study

Official title: PERSPECT: Patient Experience Recommender System for Persuasive Communication Tailoring

The purpose of this study is to maximize patient perspective and effectively support lifestyle choices, investigators will develop the "Patient Experience Recommender System for Persuasive Communication Tailoring." PERSPeCT is a computer system that will assess adult smokers' perspective, to understand the patient's preferences for smoking cessation health messages, and provide personalized, persuasive health communication that is useful to the individual patient in making positive health behavior changes such as smoking cessation.

Read the detailed description

To maximize patient perspective and effectively support lifestyle choices, we will develop the "Patient Experience Recommender System for Persuasive Communication Tailoring." PERSPeCT is an adaptive computer system that will assess a patient's individual perspective, understand the patient's preferences for health messages, and provide personalized, persuasive health communication relevant to the individual patient.

Investigators propose to overcome key weaknesses in existing top-down expert-driven health communication interventions by applying advanced machine learning algorithms to adaptively recommend messages based on the "collective intelligence" of thousands of patients. This work will leverage a paradigm-shifting "Web 2.0" approach to adaptive personalization with the potential for broad impact on the field of computer tailored health communication (CTHC).

Using knowledge from scientific experts, current CTHC interventions collect baseline patient "profiles" and then use expert-written, rule-based systems to target messages to subsets of patients. These market segmentation interventions show some promise in helping certain patients reach lifestyle goals. Although theoretically sound, rule-based systems may not account for socio-cultural concepts that have intrinsic importance to the targeted population, thus limiting their relevance. Further, the rules do not adapt to patient feedback.

Outside healthcare, companies like Google, Amazon, Netflix and Pandora have made extensive use of adaptive recommendation systems to provide content with enhanced personal relevance. These systems use machine learning algorithms to derive personalized recommendations from a variety of data sources including preference feedback collected from individual users.

Within the scope of this Patient-Centered Outcomes Research Institute (PCORI) pilot, investigators will address the challenges of adapting machine learning recommender systems to CTHC in the specific context of patient decision support for smoking cessation. Investigators have chosen this domain because smoking is a major preventable cause of death, and because we have an existing database of 1,000 persuasive messages developed in a current federal grant (R01 CA129091). Specific study aims are to:

Aim 1: Collect Explicit Feedback data in order to train PERSPeCT Recruit 700 smokers using multiple, complimentary strategies, and using a web interface, ask smokers to provide (a) Perspectives on smoking and quitting and socio-cultural context information and (b) Ratings of the influential aspect of smoking cessation messages.

Aim 2: Design, Implement and Validate a customized recommendation framework This will involve (a) developing and implementing a machine learning recommender system that integrates patient profiles, message metadata, web site views and influence ratings, and (b)training the model and validating its predictive performance.

Aim 3: Conduct a pilot randomized trial (n = 120 smokers) of PERSPeCT. Investigators hypothesize that the PERSPeCT system will (H1) Select messages of increasing influence as smokers provide more message ratings and (H2) Select messages with better influence than a rule-based CTHC system when smokers provide a sufficient number of ratings CTHC systems support patient decisions about behaviors, lifestyles, and choices. PERSPeCT addresses areas of interest for PCORI, namely: 1) Identifying, testing, and/or evaluating methods that can be used to assess the patient perspective when researching behaviors, lifestyles, and choices within the patient's control; and 2) Developing, refining, testing, and/or evaluating patient-centered approaches, including decision support tools. The study team is uniquely positioned to accomplish these ambitious aims within the scope of this PCORI pilot because investigators will utilize an existing database of persuasive messages from a previous study, two years of data on the effectiveness of these messages and a trans-disciplinary team with expertise in health communication, web systems engineering, and machine learning recommender systems.

Being tested
PERSPeCT Recommender System
Keywords
Smoking Cessation, Persuasive Communication Tailoring, Health Behavior Change, Patient decision support
Medical subject headings
Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PERSPeCT Recommender SystemOther

    PERSPeCT will use data to predict messages that would be most influential to the participant in health behavioral change.

    "Patient Experience Recommender System for Persuasive Communication Tailoring." PERSPeCT is an adaptive computer system that will assess a patient's individual perspective, understand the patient's preferences for health messages, and provide personalized, persuasive health communication relevant to the individual patient.

Study groups in NCT02200432
Study groupRoleWhat they receive
ControlNo interventionThe study's current rule-based CTHC system is embedded within the Decide2Quit.org web service. Control smokers will receive the current Decide2Quit.org system, including informational web pages, an interactive quit plan, plus pushed email messages. The messages will be selected using the current rule-based CTHC system. The CTHC selects messages based on decision rules (e.g: readiness to quit, gender) using information from a smoker's baseline profile. Participants will receive one message per day for 30 days
InterventionExperimentalThe PERSPeCT intervention smokers will receive all components of the Decide2Quit.org web service, but persuasive email messages will be selected by the PERSPeCT recommender system developed in Aim 2. PERSPeCT will use data (see Figure 1) to predict messages that would be most influential to the participant. Intervention smokers will receive one PERSPeCT-generated message per day for 30 days. With each message rating, the PERSPeCT system will further adapt to patient preferences.
Receives: Other: PERSPeCT Recommender System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. message influence

    To evaluate the success of PERSPeCT in motivating smokers, we will conduct a pilot randomized trial. We hypothesize that the messages delivered by PERSPeCT will be more influential in encouraging a quit attempt, as compared with messages selected to be delivered by our current rule-based computer tailored messaging system.

    Measured: up to five months post data collection

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2014 (estimated)
  2. Study startMay 2014
  3. Primary completionMar 2015
  4. Study completionJun 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
972 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02200432
Sponsor's protocol ID
14762
Acronym
PERSPECT
Status last verified
Jul 2015
First submitted
15 Jul 2014
Last updated
9 Jul 2015
Results posted
No
Data monitoring committee
No

Publications

  • Faro JM, Nagawa CS, Allison JA, Lemon SC, Mazor KM, Houston TK, Sadasivam RS. Comparison of a Collective Intelligence Tailored Messaging System on Smoking Cessation Between African American and White People Who Smoke: Quasi-Experimental Design. JMIR Mhealth Uhealth. 2020 Apr 27;8(4):e18064. doi: 10.2196/18064.

    PubMed 32338619
  • Sadasivam RS, Borglund EM, Adams R, Marlin BM, Houston TK. Impact of a Collective Intelligence Tailored Messaging System on Smoking Cessation: The Perspect Randomized Experiment. J Med Internet Res. 2016 Nov 8;18(11):e285. doi: 10.2196/jmir.6465.

    PubMed 27826134

Questions about this trial

What is this clinical trial studying?

A study testing PERSPeCT Recommender System in people with Smoking Cessation, run by University of Massachusetts, Worcester at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jul 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

message influence (time frame: up to five months post data collection). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02200432, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in